Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Kura Oncology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 182 | 1 | 200 | +19 |
| Shares | 82.1M | 11.7K | 83.9M | +1.83M (+2.2%) |
| Value | $473.6M | $67.5K | $742.6M | +$269.0M (+56.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Kura Oncology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (24)
Institutions that held Kura Oncology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Foresite Capital Management IV, LLC | 816,882 | $4.71M |
| TCG Crossover Management, LLC | 735,184 | $4.24M |
| Walleye Capital LLC | 414,322 | $2.39M |
| Apis Capital Advisors, LLC | 180,000 | $1.04M |
| D. E. Shaw & Co., Inc. | 140,713 | $811.9K |
| Nebula Research & Development LLC | 121,884 | $703.3K |
| Magnetar Financial LLC | 76,329 | $440.4K |
| Squarepoint Ops LLC | 64,705 | $373.3K |
| Axq Capital, LP | 45,472 | $262.4K |
| Fox Run Management, L.L.C. | 31,546 | $182.0K |
| Verition Fund Management LLC | 30,766 | $177.5K |
| EntryPoint Capital, LLC | 30,025 | $173.2K |
| Amundi | 26,950 | $156.6K |
| Stonepine Capital Management, LLC | 25,000 | $144.3K |
| Bridgefront Capital, LLC | 18,708 | $107.9K |
| CI Private Wealth, LLC | 13,838 | $79.8K |
| Two Sigma Securities, LLC | 11,873 | $68.5K |
| Virtu Financial LLC | 11,283 | $65.0K |
| Raymond James Financial Inc | 314 | $1.81K |
| Federated Hermes, Inc. | 291 | $1.68K |
| Skopos Labs, Inc. | 268 | $1.55K |
| Bare Financial Services, Inc | 88 | $508 |
| Kilter Group LLC | 40 | $231 |
| CIBC Private Wealth Group, LLC | 9 | $52 |
Not filed for Q3 2025 yet (1)
Institutions that held Kura Oncology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| E Fund Management Co., Ltd. | 11,702 | $67.5K |